Submission Details
| 510(k) Number | K170317 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 01, 2017 |
| Decision Date | October 23, 2017 |
| Days to Decision | 264 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K170317 is an FDA 510(k) clearance for the Alinity i Total ?-hCG Reagent Kit, Alinity i System, a System, Test, Human Chorionic Gonadotropin (Class II — Special Controls, product code DHA), submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on October 23, 2017, 264 days after receiving the submission on February 1, 2017. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1155.
| 510(k) Number | K170317 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 01, 2017 |
| Decision Date | October 23, 2017 |
| Days to Decision | 264 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | DHA — System, Test, Human Chorionic Gonadotropin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1155 |